We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+4.26%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.92B
AUM Growth
+$1.77B
Cap. Flow
+$1.61B
Cap. Flow %
27.24%
Top 10 Hldgs %
29.35%
Holding
6,215
New
374
Increased
3,547
Reduced
1,424
Closed
549

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$87.5M
2
AAPL icon
Apple
AAPL
+$68.6M
3
AMZN icon
Amazon
AMZN
+$62.8M
4
META icon
Meta Platforms (Facebook)
META
+$41.4M
5
AMD icon
Advanced Micro Devices
AMD
+$39.4M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$158M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$70.2M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$34.4M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$33.9M
5
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$22.9M

Sector Composition

Rank Sector Weight
1 Technology 29.49%
2 Consumer Discretionary 9.8%
3 Financials 9.15%
4 Healthcare 9.12%
5 Communication Services 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANVS icon
3276
Annovis Bio
ANVS
$76.6M
$39.5K ﹤0.01%
6,858
+2,060
+43% +$16.7K
RCI icon
3277
Rogers Communications
RCI
$19.4B
$39.5K ﹤0.01%
1,068
-39,401
-97% -$1.53M
MLYS icon
3278
Mineralys Therapeutics
MLYS
$2.38B
$39.4K ﹤0.01%
3,371
+3,076
+1,043% +$38.7K
PENN icon
3279
PENN Entertainment
PENN
$2.57B
$39.4K ﹤0.01%
2,036
-8,331
-80% -$141K
CDLX icon
3280
Cardlytics
CDLX
$24.7M
$39.4K ﹤0.01%
479
+79
+20% +$8.54K
PFF icon
3281
iShares Preferred and Income Securities ETF
PFF
$13.3B
$39.3K ﹤0.01%
+1,247
New +$39.3K
CHMG icon
3282
Chemung Financial Corp
CHMG
$401M
$39.3K ﹤0.01%
819
+787
+2,459% +$33.6K
HBIO icon
3283
Harvard Bioscience
HBIO
$27.8M
$39.2K ﹤0.01%
1,376
+1,339
+3,619% +$47K
EBTC
3284
DELISTED
Enterprise Bancorp
EBTC
$39.1K ﹤0.01%
1,573
+1,554
+8,179% +$38.1K
ASUR icon
3285
Asure Software
ASUR
$241M
$39.1K ﹤0.01%
4,651
+4,230
+1,005% +$32K
IWS icon
3286
iShares Russell Mid-Cap Value ETF
IWS
$16B
$39K ﹤0.01%
323
-2,456
-88% -$298K
BHR
3287
Braemar Hotels & Resorts
BHR
$139M
$38.9K ﹤0.01%
15,274
+11,317
+286% +$29.8K
ATNM icon
3288
Actinium Pharmaceuticals
ATNM
$25.8M
$38.9K ﹤0.01%
5,263
+2,915
+124% +$24K
TMCI icon
3289
Treace Medical Concepts
TMCI
$309M
$38.9K ﹤0.01%
5,856
+5,613
+2,310% +$45.3K
CIG icon
3290
CEMIG Preferred Shares
CIG
$5.61B
$38.9K ﹤0.01%
22,112
-4,209
-16% -$8.05K
RMNI icon
3291
Rimini Street
RMNI
$445M
$38.8K ﹤0.01%
12,653
+6,329
+100% +$17.4K
AZEK
3292
DELISTED
The AZEK Co
AZEK
$38.8K ﹤0.01%
920
-1,337
-59% -$61.9K
PACK icon
3293
Ranpak Holdings
PACK
$464M
$38.7K ﹤0.01%
6,014
+4,228
+237% +$28.6K
WVE icon
3294
Wave Life Sciences
WVE
$1.03B
$38.7K ﹤0.01%
7,748
+7,220
+1,367% +$41.2K
AVAH icon
3295
Aveanna Healthcare
AVAH
$1.97B
$38.6K ﹤0.01%
13,995
+6,653
+91% +$16.6K
PXH icon
3296
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.97B
$38.4K ﹤0.01%
1,895
+1,868
+6,919% +$37.7K
TEF
3297
DELISTED
Telefonica
TEF
$38.4K ﹤0.01%
9,114
+7,628
+513% +$33.7K
DFEN icon
3298
Direxion Daily Aerospace & Defense Bull 3X ETF
DFEN
$433M
$38.3K ﹤0.01%
1,482
-19,256
-93% -$513K
MRVI icon
3299
Maravai LifeSciences
MRVI
$861M
$38.3K ﹤0.01%
5,343
-19,318
-78% -$167K
VYM icon
3300
Vanguard High Dividend Yield ETF
VYM
$84B
$38.2K ﹤0.01%
322
-4,321
-93% -$512K
130 131
132
133 134

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2024 Portfolio in Review

As of Q2 2024, Tower Research Capital (TRC) held 6,215 positions worth $5.92B, up 43% from $4.15B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $1.61B of net new capital in Q2 2024, opening 374 new positions and adding to 3,547 existing holdings. Its largest new stake was State Street Financial Select Sector SPDR ETF: 480,124 shares worth $19.7M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $158M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2024 buy was State Street Financial Select Sector SPDR ETF: 480,124 shares worth $19.7M.
  • Tower Research Capital (TRC) added most to Microsoft in Q2 2024, an estimated $87.5M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $158M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P Mid-Cap ETF in Q2 2024, selling an estimated $18.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $5.92B portfolio in Q2 2024.
  • Tower Research Capital (TRC) opened 374 new positions and closed 549 in Q2 2024.
  • Tower Research Capital (TRC)'s portfolio value rose 43% quarter-over-quarter to $5.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2024, filed 13 Aug 2024.